Tyme Technologies

+$0.0156 (+1.62%) Today
-$0.0066 (-0.68%) As of 9:44 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TYME and other ETFs, options, and stocks.

About TYME

Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis.

CEO
Richard Anthony Cunningham
Employees
17
Headquarters
Bedminster, New Jersey
Founded
2011

TYME Key Statistics

Market Cap
168.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
813.93K
High Today
$0.9825
Low Today
$0.965
Open Price
$0.97
Volume
727.33K
52 Week High
$4.99
52 Week Low
$0.85

TYME Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure